Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 481 AL 495

Microglial NLRP3 Inflammasomes in Alzheimer's Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics

Ayyubova G, Madhu LN.

Mol Neurobiol. 2025 Jun;62(6):7124-7143. doi: 10.1007/s12035-025-04758-z. Epub 2025 Feb 14.

Microglial Modulation in Alzheimer's Disease: Central Players in Neuroinflammation and Pathogenesis

Hussain MS, Khan Y, Fatima R, Maqbool M, Ramalingam PS, Khan MG, Bisht AS.

Curr Alzheimer Res. 2025;22(1):56-82. doi: 10.2174/0115672050364292250113063513.

The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias

Huang C, Wei Z, Zheng N, Yan J, Zhang J, Ye X, Zhao W.

Alzheimers Dement. 2025 Feb;21(2):e14618. doi: 10.1002/alz.14618.

Unlocking the therapeutic promise of miRNAs in promoting amyloid-β clearance for Alzheimer's disease

Kaur V, Sunkaria A.

Behav Brain Res. 2025 Apr 27;484:115505. doi: 10.1016/j.bbr.2025.115505. Epub 2025 Feb 25.

The Peripheral Amyloid-β Nexus: Connecting Alzheimer's Disease with Atherosclerosis through Shared Pathophysiological Mechanisms

Khowdiary MM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Elhenawy AA, Rashwan EK, Alexiou A, Papadakis M, Fetoh MEA, Batiha GE.

Neuromolecular Med. 2025 Mar 3;27(1):20. doi: 10.1007/s12017-025-08836-2.

Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery

Alsaleem MA, Al-Kuraishy HM, Al-Gareeb AI, Abdel-Fattah MM, Alrouji M, Al-Harchan NA, Alruwaili M, Papadakis M, Alexiou A, Batiha GE.

J Cell Mol Med. 2025 Mar;29(5):e70378. doi: 10.1111/jcmm.70378.

Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies

Dahiya M, Yadav M, Goyal C, Kumar A.

Inflammopharmacology. 2025 Apr;33(4):1817-1831. doi: 10.1007/s10787-025-01704-2. Epub 2025 Mar 10.

Cellular Prion Protein and Amyloid-β Oligomers in Alzheimer's Disease-Are There Connections?

Fułek M, Hachiya N, Gachowska M, Beszłej JA, Bartoszewska E, Kurpas D, Kurpiński T, Adamska H, Poręba R, Urban S, Fułek K, Leszek J.

Int J Mol Sci. 2025 Feb 27;26(5):2097. doi: 10.3390/ijms26052097.

The role of n-3-derived specialised pro-resolving mediators (SPMs) in microglial mitochondrial respiration and inflammation resolution in Alzheimer's disease

Slayo M, Rummel C, Singhaarachchi PH, Feldotto M, Spencer SJ.

Mol Neurodegener. 2025 Mar 21;20(1):35. doi: 10.1186/s13024-025-00824-1.

GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression

Rekha A, Afzal M, Babu MA, Menon SV, Nathiya D, Supriya S, Mishra SB, Gupta S, Goyal K, Rana M, Ali H, Imran M.

Mol Cell Neurosci. 2025 Jun;133:104005. doi: 10.1016/j.mcn.2025.104005. Epub 2025 Mar 20.

Deciphering T Cell Dynamics in Alzheimer's Disease Pathogenesis: Insights and Implications

Yang Q, Qiu Y, Ni J, Li H, Qing H.

Curr Neuropharmacol. 2025;23(12):1533-1550. doi: 10.2174/011570159X350611250303044527.

Microglia efferocytosis: an emerging mechanism for the resolution of neuroinflammation in Alzheimer's disease

Chen Y, Kou Y, Ni Y, Yang H, Xu C, Fan H, Liu H.

J Neuroinflammation. 2025 Mar 30;22(1):96. doi: 10.1186/s12974-025-03428-0.

Mitochondrial Genome Variants and Alzheimer's Disease

Kozin MS, Kulakova OG, Kiselev IS, Semina EV, Kakotkin VV, Agapov MA, Favorova OO.

Biochemistry (Mosc). 2025 Jan;90(Suppl 1):S146-S163. doi: 10.1134/S0006297924603174.

CaMKII mechanisms that promote pathological LTP impairments

Larsen ME, Rumian NL, Quillinan N, Bayer KU.

Curr Opin Neurobiol. 2025 Jun;92:102961. doi: 10.1016/j.conb.2024.102961. Epub 2025 Mar 31.

The endocannabinoid system offers a target for Alzheimer's disease treatment through inhibition of fatty acid amide hydrolase (FAAH)

de Ceballos ML.

FEBS J. 2025 Aug;292(16):4156-4159. doi: 10.1111/febs.70082. Epub 2025 Apr 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias